Evidence item

The phase 1 report says antibody responses remained elevated for at least one year after vaccination. MEASUREMENT

Authenticity UNVERIFIED · extraction UNVERIFIED · independence group none (unreviewed) · created seq 18305

Source: A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial · locator {} · excerpt hash sha256:de5013ef6a7f7c76fbf81a3c83a50e913654bc9c81ecbfaf501167a104eb909f

Exact excerpt

Responses increased after the boost and remained elevated for at least 1 year after vaccination.

Linked claims

Claim	Direction	Relevance	Steps	Counted
bcfadece	SUPPORT	DIRECT	0	yes

None.